| Teva Pharmaceutical Industries Limited (TEVA) | |||
|---|---|---|---|
| 9.48 0.19 (2.05%) | 09-18 16:00 | ||
| Open: | 9.35 | Pre. Close: | 9.29 |
| High: | 9.51 | Low: | 9.25 |
| Volume: | 6,346,029 | Market Cap: | 10,385M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 9.516 - 9.544 | 9.544 - 9.575 |
| Low: | 9.165 - 9.199 | 9.199 - 9.237 |
| Close: | 9.419 - 9.471 | 9.471 - 9.53 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 12.30  One year: 13.67 |
| Support: | Support1: 8.65 Support2: 7.20 |
| Resistance: | Resistance1: 10.53 Resistance2: 11.70 |
| Pivot: | 9.21 |
| Moving Averages: | MA(5): 9.24  MA(20): 9.32 MA(100): 11.32 MA(250): 10.24 |
| MACD: | MACD(12,26): -0.45 Signal(12,26,9): -0.56 |
| %K %D: | %K(14,3): 53.60 %D(3): 46.07 |
| RSI: | RSI(14): 44.06 |
| 52-Week: | High: 13.76 Low: 6.25 Change(%): 31.8 |
| Average Vol(K): | 3-Month: 882692 10-Days: 668342 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.TEVA has closed below upper band by 28.2%. Bollinger Bands are 42.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to TEVA's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency |  |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers General Specialty & Generic | |
| Shares Out. (M) | 1100.00 |
| Shares Float (M) | 1090.00 |
| % Held by Insiders | 0.60 |
| % Held by Institutions | 54.67 |
| Shares Short (K) | 23020 |
| Shares Short Prior Month (K) | 22570 |
| Stock Financials | |
|---|---|
| EPS | |
| Book Value (p.s.) | 12.640 |
| Profit Margin | 0.02 |
| Operating Margin | 18.06 |
| Return on Assets (ttm) | 3.3 |
| Return on Equity (ttm) | |
| Qtrly Rev. Growth | -7.3 |
| Gross Profit (p.s.) | 6.855 |
| Sales Per Share | 15.264 |
| EBITDA (p.s.) | 4.218 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | 1440.00 |
| Levered Free Cash Flow (M) | 2310.00 |
| Stock Valuation | |
|---|---|
| PE Ratio | |
| PEG Ratio | 8.85 |
| Price to Book value | 0.75 |
| Price to Sales | 0.62 |
| Price to Cash Flow | 7.24 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
